Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Hemlibra (emicizumab-kxwh) - Roche
When A Fall Isn't Just a Fall: Delayed Diagnosis of Acquired Hemophilia A in a Nonagenarian Patient. (PubMed, Am J Case Rep) - Sep 27, 2026 - "During current admission, prolonged aPTT prompted further workup, revealing low factor VIII activity of 5% and a high factor VIII inhibitor titer of 15.6 Bethesda Units, establishing the diagnosis of acquired hemophilia A. Bleeding control required sequential bypassing agents, corticosteroids, rituximab, cyclophosphamide, and eventually emicizumab. Basic coagulation testing including prothrombin time and aPTT can help screen patients who warrant additional coagulopathy evaluation. Timely diagnosis is critical to avoid life-threatening bleeding complications." 
Journal • Hematological Disorders • Hemophilia • Hemophilia A • Mood Disorders • Pain • Rare Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42798162
 
Arjun Khunger; Prajeesh Kandoth Karerat; Swati Gobhil
 
Sep 27, 2026
 
Prev Next